QurCan Therapeutics has been selected to participate in Novo Nordisk's Co-Creation Greenhouse Program. Anchored through the Novo Nordisk Bio Innovation Hub, this collaboration provides QurCan with funding and deep scientific and technical expertise in translational and drug development.
QurCan Therapeutics is an OBIO® member, an alumnus of the BDSP™, CAAP® and HealthMINT™ programs and presented at the OBIO® Investment Summit.